National diabetes registries confer clear insights into diagnostics, complications, and treatment. The extent to which registries influenced national healthcare policy was less clear (Acta Diabetologica)
Diabetes News
Category: Audits
Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit
We show that the use of FSL was associated with significantly improved glycemic control and hypoglycemia awareness and a reduction in hospital admissions (Diabetes Care)
ABCD COVID-19 & Diabetes: UK national audit
This audit aims to explore the clinical features and presentation of people admitted with diabetes and COVID-19. Through capturing detailed real-world data on the clinical presentation, co-morbidities, therapies and outcomes we hope to gain better insight into the impact of COVID-19 on those living with diabetes (ABCD)
Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation
This analysis shows that additional cost of provision of hospital services due to their diabetes comorbidities is £3 billion above that for non-diabetes, and that within this, T1DM has three times as much cost impact as T2DM. We suggest that supporting patients in diabetes management may significantly reduce hospital activity (BMJ)
Diabetes care – examining whether patients with diabetes receive the recommended care and treatment
Here we use data from the National Diabetes Audit and National Paediatric Diabetes Audit to look at how the quality of care for diabetics has changed over time (Nuffield Trust)
National Paediatric Diabetes Audit – Annual report 2018-19
The National Paediatric Diabetes Audit assess the care received by children and young people with diabetes in all Paediatric Diabetes Units (PDUs) across England and Wales (HQIP)
National Diabetes Statistics Report
Estimates of Diabetes and Its Burden in the United States (CDC)
Diabetes Prevention Programme – Quarterly Report, January to September 2019
This is the quarterly release of non-diabetic hyperglycaemia data collected from GP practices alongside the National Diabetes Audit (NDA)
National Diabetes Audit – Care Processes and Treatment Targets, January to September 2019
This is the quarterly release of data from the National Diabetes Audit
Diabetes UK Position Statements
Diabetes continues to place a significant burden on the individual with diabetes and wider UK society. This report will be updated annually to understand how diabetes is changing across the UK (Diabetic Medicine)
National Diabetes Audit Report 1 – Care Processes and Treatment Targets 2018-19, Short Report
This short report details the top-level findings for the 2018-19 audit. The full report, scheduled for 2020, will contain full key findings, recommendations and results of new analyses into HbA1c check frequencies and blood glucose drug cohorts (NHS Digital)
Diabetes Prevention Programme 2018-19, Short Report
This report is for England only. Unlike the NDA, it does not include information on Wales (NHS Digital)
Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents
Results from the International Diabetes Federation Diabetes Atlas, 9th edition (Diabetes Research and Clinical Practice)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045
Results from the International Diabetes Federation Diabetes Atlas, 9th edition (Diabetes Research and Clinical Practice)
IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018
This study illustrated difficulties in deriving a meaningful global prevalence rate for DR and DME due to the lack of uniformity in defining the study populations, methodological differences, retinal image capture and grading criteria. Therefore, international consensus is required using a minimal data set for future studies (Diabetes Research and Clinical Practice)
Early Outcomes From the English National Health Service Diabetes Prevention Program
Reductions in weight and HbA1c compare favorably with those reported in recent meta-analyses of pragmatic studies and suggest likely future reductions in participant type 2 diabetes incidence (Diabetes Care)
Prescribing for Diabetes in England 2008/09 – 2018/19
This publication reports on trends in the prescribing of medicines for the treatment and monitoring of diabetes in England from 2008/09 to 2018/19 (NHS Digital)
National Pregnancy in Diabetes Audit Report 2018
The National Pregnancy in Diabetes Audit (NPID) is a workstream of the National Diabetes Audit (NDA) and is managed by NHS Digital under an agreement with the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England and the Welsh Government
Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes
This synopsis focuses on selected guidance relating to use of diabetes technology in adults with diabetes. Recommendations address self-monitoring of blood glucose, continuous glucose monitors, and automated insulin delivery systems (Annals of Internal Medicine)
Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017
Since 1995, insulin pump use has continuously increased, and insulin pump therapy is now standard in patients aged <15 years. CGM use sharply rose in recent years, particularly in young children (Diabetes Care)
- 1
- 2
- 3
- …
- 8
- Next Page »
Glycosmedia is also available as an App: